Defect in mitochondrial oxidative phosphorylation have been linked to insulin resistance [28], and there is also evidence suggesting that polymorphisms in PPARGC1A are associated with an increased relative risk of type 2 diabetes, defects in insulin secretion, and lipid oxidation [29]. Here, INS is linked to type 2 diabetes mellitus.